Sargent Bickham Lagudis’s Express Scripts Holding Company ESRX Stock Holding History

Sargent Bickham Lagudis’s Portfolio ESRX Stock Details ESRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,269	Closed	-$302K	–	809
2019 Q2	$302K	Hold	3,269	–	–	0.04%	174
2019 Q1	$302K	Hold	3,269	–	–	0.04%	183
2018 Q4	$302K	Sell	3,269 -644	-16%	-$62.2K	0.04%	170
2018 Q3	$372K	Hold	3,913	–	–	0.04%	159
2018 Q2	$302K	Sell	3,913 -127	-3%	-$9.53K	0.04%	164
2018 Q1	$279K	Hold	4,040	–	–	0.03%	173
2017 Q4	$302K	Hold	4,040	–	–	0.04%	174
2017 Q3	$256K	Hold	4,040	–	–	0.03%	195
2017 Q2	$258K	Hold	4,040	–	–	0.03%	183
2017 Q1	$266K	Sell	4,040 -55	-1%	-$3.78K	0.03%	184
2016 Q4	$282K	Sell	4,095 -300	-7%	-$21.5K	0.04%	167
2016 Q3	$310K	Sell	4,395 -1,034	-19%	-$77.3K	0.05%	165
2016 Q2	$412K	Sell	5,429 -379	-7%	-$27.9K	0.06%	145
2016 Q1	$399K	Buy	+5,808	New	+$418K	0.06%	149

Other funds holding ESRX

CBT

Capital Bank & Trust Irvine, California $3.15M AUM 32.15% 1-Year Est. Return

Sargent Bickham Lagudis's ESRX Position: Q3 2019 in Review

Sargent Bickham Lagudis sold out of Express Scripts Holding Company (ESRX) in Q3 2019, closing a stake of 3,269 shares — an estimated $302K sold.

Sargent Bickham Lagudis first reported a position in ESRX in Q1 2016 and held it in 14 quarters. The position peaked at $412K in Q2 2016. 1 fund tracked by Wall St. Rank holds ESRX as of Q3 2019.

Sargent Bickham Lagudis reported no remaining Express Scripts Holding Company position as of Q3 2019 after selling out during the quarter.
Sargent Bickham Lagudis sold 3,269 Express Scripts Holding Company shares in Q3 2019, an estimated $302K.
Sargent Bickham Lagudis first reported a position in Express Scripts Holding Company in Q1 2016 and held it in 14 quarters.
Sargent Bickham Lagudis's Express Scripts Holding Company position peaked at $412K in Q2 2016.
1 fund tracked by Wall St. Rank held Express Scripts Holding Company as of Q3 2019.

Based on Sargent Bickham Lagudis's 13F filing for Q3 2019, filed 14 Sep 2021.